{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:27:34Z","timestamp":1790173654710,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Research Intellect Disabil"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There are concerns that antipsychotics may be used inappropriately in adults with intellectual disability for problem behaviours in the absence of a diagnosed mental health condition. The aim was to examine the prevalence and patterns of antipsychotic use and their association with problem behaviours and mental health conditions in older adults with intellectual disability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross\u2010sectional data were drawn from Wave 2 (2013\/2014) of the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (<jats:styled-content style=\"fixed-case\">IDS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TILDA<\/jats:styled-content>). Medication data were available for 95.6% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0677). Those who reported antipsychotic use and reported psychotic or other mental health conditions and those who reported problem behaviours were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 45.1% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0305) had antipsychotics, and of those with antipsychotic use and diagnosis information (<jats:italic>n<\/jats:italic>\u00a0=\u00a0282), 25.9% (73) had a psychotic disorder. 58% of those exposed to antipsychotics reported problem behaviours.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Reported use of antipsychotics significantly exceeded reported doctor's diagnosis of psychotic conditions in this study.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jar.12591","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T02:48:21Z","timestamp":1556678901000},"page":"981-993","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities"],"prefix":"10.1111","volume":"32","author":[{"given":"Claire","family":"O'Dwyer","sequence":"first","affiliation":[{"name":"IDS\u2010TILDA School of Nursing and Midwifery Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McCallion","sequence":"additional","affiliation":[{"name":"School of Social Work, College of Public Health Temple University Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Henman","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McCarron","sequence":"additional","affiliation":[{"name":"Dean of the Faculty of Health Sciences Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"O'Leary","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-8048","authenticated-orcid":false,"given":"Eilish","family":"Burke","sequence":"additional","affiliation":[{"name":"IDS\u2010TILDA School of Nursing and Midwifery Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"O'Connell","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-4903","authenticated-orcid":false,"given":"M\u00e1ire","family":"O'Dwyer","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"Ageing E. L. S. O.(2002).ELSA Wave 1 Questionnaire."},{"key":"e_1_2_9_3_1","unstructured":"Alexander R. Branford D. &Devapriam J.(2016).Psychotropic drug prescribing for people with intellectual disability mental health problems and\/or behaviours that challenge: Practice guidelines.http:\/\/www.rcpsych.ac.uk\/pdf\/FR_ID_09_for_website.pdf"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jppi.12241"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118897164"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03350.x"},{"key":"e_1_2_9_7_1","unstructured":"Burke E. McCarron M. &McCallion P.(2014).Advancing years different challenges: Wave 2 IDS\u2010TILDA findings of the ageing of people with intellectual disability.https:\/\/www.tcd.ie\/tcaid\/assets\/pdf\/Wave_2_Report_October_2014.pdf"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1353\/etc.0.0041"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3282ab9952"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12119"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/13668250.2013.778968"},{"key":"e_1_2_9_12_1","unstructured":"England N.(2016).Stopping over\u2010medication of people with learning disabilities 2016."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-2093-2"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.141267"},{"key":"e_1_2_9_15_1","unstructured":"Health N. C. C. F. M.(2015).Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges."},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717727240"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3283422424"},{"key":"e_1_2_9_18_1","unstructured":"McCarron M. Swinburne J. Burke E. McGlinchey E. Mulryan N. Andrews V. \u2026McCallion P.(2011b).Growing older with an intellectual disability in Ireland 2011: First results from the intellectual disability supplement of The Irish Longitudinal Study on Ageing School of Nursing Trinity College Dublin."},{"key":"e_1_2_9_19_1","unstructured":"McCarron M. Swinburne J. Burke E. McGlinchey E. Mulryan N. Andrews V. \u2026McCallion P.(2011a).Growing older with an intellectual disability in Ireland 2011: First results from the intellectual disability supplement to the Irish longitudinal study on ageing.https:\/\/www.tcd.ie\/tcaid\/assets\/pdf\/idstildareport2011.pdf"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10882-005-6614-7"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3148.2005.00251.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2788.2003.00511.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13479"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.173971"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2018.05.007"},{"issue":"4","key":"e_1_2_9_26_1","first-page":"e010505","article-title":"Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: A cross\u2010sectional observational nationwide study","volume":"6","author":"O'Dwyer M.","year":"2016","journal-title":"British Medical Journal Open"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12391"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2011.01421.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2004.05.029"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jar.12426"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4326"},{"issue":"8","key":"e_1_2_9_33_1","first-page":"e017406","article-title":"Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population\u2010based cohort study","volume":"7","author":"Sheehan R.","year":"2017","journal-title":"British Medical Journal Open"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-26583-4"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1352\/0895-8017(2004)109<322:SLSOPM>2.0.CO;2"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.109.027086"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1617-6"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60072-0"},{"key":"e_1_2_9_39_1","unstructured":"WHO W. H. O.Anatomical chemical therapeutic classification system. Retrieved fromhttp:\/\/www.whocc.no\/atc\/structure_and_principles\/"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0607"}],"container-title":["Journal of Applied Research in Intellectual Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjar.12591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jar.12591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jar.12591","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jar.12591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T19:29:48Z","timestamp":1694374188000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jar.12591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/jar.12591"],"URL":"https:\/\/doi.org\/10.1111\/jar.12591","archive":["Portico"],"relation":{},"ISSN":["1360-2322","1468-3148"],"issn-type":[{"value":"1360-2322","type":"print"},{"value":"1468-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"2018-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}